Granuloma
10
3
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
20%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children
Hypercalcemia After Paraffin Oil Injection
PRF Membrane and Recovery After Periapical Surgery: A 3D Imaging Study
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Treatment of Tracheostomy Granulomas
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord